Philip W. Kantoff

Also affiliated with Convergent Science (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064

Top 100%

0DataRank

Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Papers

Driven by 27 papers — median percentile 0. Top paper: “Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry”.

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0213-7

N/A

4.8DataRank · unranked

145 citations

Andrew J. Armstrong, Chiledum Ahaghotu, David G. McLeod, Matthew R. Cooperberg, David F. Penson +17 more

The genomic complexity of primary human prostate cancer

Nature(2011)10.1038/nature09744

N/A

1.1DataRank · unranked

1250 citations

Michael S. Lawrence, Francesca Demichelis, Timothy R. Dreszer, Kristian Cibulskis, Sachet A. Shukla +36 more

Clinical Outcomes of First-line Abiraterone Acetate or Enzalutamide for Metastatic Castration-resistant Prostate Cancer After Androgen Deprivation Therapy + Docetaxel or ADT Alone for Metastatic Hormone-sensitive Prostate Cancer

Clinical Genitourinary Cancer(2018)10.1016/j.clgc.2017.12.012

N/A

1.1DataRank · unranked

19 citations

Steven Yip, Shubidito Ahmed, Haocheng Li, Luke Ardolino, Carolyn P. Evan +9 more

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0446

N/A

0.414DataRank · unranked

8 citations

Natalie Slopen, Hannah D. McManus, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain +24 more

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases

Nature Communications(2025)10.1038/s41467-025-56944-1

N/A

0.406DataRank · unranked

14 citations

Niedzica Camacho, Patrick R. Shea, Konrad H. Stopsack, Vijai Joseph, Oliver S. Burren +29 more

Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell–Level PI3K Pathway Activation

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2000

N/A

0.396DataRank · unranked

13 citations

Ying Huang, Svitlana Tyekucheva, Travis Gerke, Clyde Bango, Habiba Elfandy +8 more

ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation

Bioinformatics(2024)10.1093/bioinformatics/btae121

N/A

0.373DataRank · unranked

11 citations

Alex Panchot, E. E. Schmidt, Samantha N. McNulty, Brian Wiley, Jie Liu +21 more

The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer

JNCI Cancer Spectrum(2022)10.1093/jncics/pkac035

N/A

0.373DataRank · unranked

11 citations

Vaibhav G. Patel, Xiaobo Zhong, Luis A. Pina, Jessica E. Hawley, Emily Lin +17 more

Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US

Quality of Life Research(2023)10.1007/s11136-023-03468-0

N/A

0.345DataRank · unranked

9 citations

Natalie Slopen, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain, Pedro C. Barata +18 more

Fraction genome altered (FGA) to regulate both cell autonomous and non-cell autonomous functions in prostate cancer and its effect on prostate cancer aggressiveness.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.347

N/A

0.330DataRank · unranked

8 citations

Arnab Ghosh, Subhiksha Nandakumar, Joshua Armenia, Ying Z. Mazzu, Mohammad Atiq +6 more

Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting

PLoS ONE(2024)10.1371/journal.pone.0301989

N/A

0.241DataRank · unranked

4 citations

Romina Ghale, Subhiksha Nandakumar, Kalyani Chadalavada, Gwo‐Shu Mary Lee, Konrad H. Stopsack +5 more

Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)

Cancer Genetics(2021)10.1016/j.cancergen.2021.08.004

N/A

0.241DataRank · unranked

4 citations

William L. Hwang, Jimmy A. Guo, Hannah I. Hoffman, Matthew C. Abramowitz, Ziad El-Bakouny +24 more

Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.29.450369

N/A

0.208DataRank · unranked

3 citations

Svitlana Tyekucheva, Molin Wang, Travis Gerke, Jane B. Vaselkiv, Kathryn L. Penney +8 more

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways

Cell Reports(2025)10.1016/j.celrep.2025.115779

N/A

0.165DataRank · unranked

2 citations

Subhiksha Nandakumar, Nabila Zaman, Prathiksha Prabhakaraalva, Sarah Ann King, Teja Kalidindi +19 more

Experience with the US health care system for Black and White patients with advanced prostate cancer

Cancer(2023)10.1002/cncr.34885

N/A

0.104DataRank · unranked

1 citations

Konrad H. Stopsack, Natalie Slopen, Folakemi T. Odedina, Camille Ragin, Joel Nowak +11 more

Contributors

Genomic and Personalized Medicine(2009)10.1016/b978-0-12-369420-1.00122-0

N/A

0DataRank · unranked

0 citations

Matthew L. Anderson, Felicita Andreotti, Brian H. Annex, Anthony Antonellis, Dmitri Artemov +272 more

Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer

Carcinogenesis(2020)10.1093/carcin/bgaa061

N/A

0DataRank · unranked

6 citations

Travis Gerke, Piotr Zareba, Andreas Pettersson, Dipanjan Chowdhury, Ericka M. Ebot +8 more

Effects of electroacupuncture and auricular acupuncture for chronic pain in cancer survivors: The PEACE randomized controlled trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12004

N/A

0DataRank · unranked

2 citations

Kevin T. Liou, Katherine S. Panageas, Raymond E. Baser, Sally A.D. Romero, Qing Susan Li +4 more

Tumor protein expression of BRCA1 and development of lethal prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.65

N/A

0DataRank · unranked

0 citations

Travis Gerke, Piotr Zareba, Andreas Pettersson, Konrad H. Stopsack, Dipanjan Chowdhury +9 more

Checkpoint kinase inhibition in prostate cancer cells resistant to poly ADP-ribose polymerase inhibitors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.150

N/A

0DataRank · unranked

0 citations

Goutam Chakraborty, Subhiksha Nandakumar, Ying Z. Mazzu, Konrad H. Stopsack, Yuki Yoshikawa +3 more

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064

Top 100%

0DataRank

Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Data from Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells

(2023)10.1158/1078-0432.c.6530786.v1

N/A

0DataRank · unranked

0 citations

Zhouwei Zhang, Hannah Kimball, Fangfang Qu, Kyler Berlind, Konrad H. Stopsack +4 more

Data from Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer

(2023)10.1158/1078-0432.c.6518292

Top 100%

0DataRank

Top 100%0 citations

Aaron R. Thorner, Mark A. Rubin, Massimo Loda, Philip W. Kantoff, William Oh +3 more

Data from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors

(2023)10.1158/1078-0432.c.6530694

N/A

0DataRank · unranked

0 citations

Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu, Yuki Yoshikawa +10 more

Data from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors

(2023)10.1158/1078-0432.c.6530694.v1

N/A

0DataRank · unranked

0 citations

Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu, Yuki Yoshikawa +10 more

Impact of 5α-reductase inhibitor and α-blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality

UNC Libraries(2024)10.17615/2hg3-ap29

N/A

0DataRank · unranked

0 citations

J. Curtis Nickel, Philip W. Kantoff, Maria I. Van Rompay, Gayatri Ranganathan, Jennifer L. Lund +2 more

Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2 -altered Prostate Tumors

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2483

N/A

0DataRank · unranked

21 citations

Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu, Yuki Yoshikawa +10 more

Philip W. Kantoff

Indexed papers

Top data-sharing exemplar

Papers